Concepedia
Statistics
Publications
118
Citations
11.2K
H-Index
47
Active since
1971
Affiliations
Technical University of Munich(Current)
Thrombosis Research Institute
Bayer (Germany)
McMaster University
Harvard University
Sylvia Haas is an author at Technical University of Munich specializing in medicine, thrombosis, and pharmacotherapy.
Top concepts
MedicineThrombosisCardiovascular DiseasePharmacotherapyHematologyPublic HealthAnesthesiologyEmergency MedicinePharmacologyOrthopedics
Publications per year
1971–2023
Rivaroxaban versus Enoxaparin for Thromboprophylaxis after Hip Arthroplasty
Bengt I. Eriksson, Lars C. Borris, Richard J. Friedman et al. · New England Journal of Medicine · 2008 · 1.4K citations · Full text
Extended duration rivaroxaban versus short-term enoxaparin for the prevention of venous thromboembolism after total hip arthroplasty: a double-blind, randomised controlled trial
Ajay K. Kakkar, Benjamin Brenner, Ola E. Dahl et al. · The Lancet · 2008 · 1.1K citations
Total Hip Arthroplasty, Thrombosis, Venous Thrombosis +8
Apixaban versus Enoxaparin for Thromboprophylaxis in Medically Ill Patients
Samuel Z. Goldhaber, Alain Leizorovicz, Ajay K. Kakkar et al. · New England Journal of Medicine · 2011 · 542 citations · Full text
XANTUS: a real-world, prospective, observational study of patients treated with rivaroxaban for stroke prevention in atrial fibrillation
A. John Camm, Pierre Amarenco, Sylvia Haas et al. · European Heart Journal · 2015 · 447 citations · Full text
Risk Profiles and Antithrombotic Treatment of Patients Newly Diagnosed with Atrial Fibrillation at Risk of Stroke: Perspectives from the International, Observational, Prospective GARFIELD Registry
Ajay K. Kakkar, Iris Mueller, Jean‐Pierre Bassand et al. · PLoS ONE · 2013 · 440 citations · Full text
1–5 of 118